Chronic Lymphocytic Leukemia Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • CLR 131 single dose
  • +2 more
  • Redlands, California
  • +14 more
2021-11-30
Nov 30, 2021
M
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-18
Nov 18, 2021
M
Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
B
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Little Rock, Arkansas
  • +144 more
2021-11-19
Nov 19, 2021
U
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • Electronic Health Record Review
  • Duarte, California
  • +11 more
2021-11-12
Nov 12, 2021
T
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
2021-11-11
Nov 11, 2021
M
Active, not recruiting
  • Body Mass Index 25 or Greater
  • +10 more
  • Dietary Intervention
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-10
Nov 10, 2021
M
Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-09
Nov 9, 2021
J
Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +166 more
2021-11-04
Nov 4, 2021
V
Recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +11 more
2021-11-02
Nov 2, 2021
M
Recruiting
  • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-10-29
Oct 29, 2021
M
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Questionnaire Administration
  • Ruxolitinib Phosphate
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-15
Oct 15, 2021
X
Recruiting
  • B-cell Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • XmAb13676
  • La Jolla, California
  • +21 more
2021-10-20
Oct 20, 2021
G
Terminated
  • Non-Hodgkin's Lymphoma
  • Chronic Lymphocytic Leukemia
  • hLL1-DOX (IMMU-115)
  • Newark, Delaware
  • +5 more
2021-10-06
Oct 6, 2021
C
A
Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Phoenix, Arizona
  • +30 more
2021-09-23
Sep 23, 2021
L
Recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Scottsdale, Arizona
  • +55 more
2021-09-17
Sep 17, 2021
A
Active, not recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • APR-246 (eprenetapopt) + Acalabrutinib in CLL
  • +3 more
  • Boston, Massachusetts
  • +3 more
2021-09-17
Sep 17, 2021
M
Completed
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-08-11
Aug 11, 2021
F
Recruiting
  • Lymphoma, B-Cell
  • +2 more
  • Westwood, Kansas
  • +2 more
2021-08-30
Aug 30, 2021
A
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • ACP-196 (acalabrutinib)
  • Tucson, Arizona
  • +22 more
2021-09-02
Sep 2, 2021
A
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +131 more
2021-08-27
Aug 27, 2021